Recursion Pharmaceuticals Company

Recursion Pharmaceuticals combines experimental biology, automation, and artificial intelligence to discover treatments in a massively parallel system to quickly and efficiently identify treatments for any disease which can be modeled at the cellular level. From its initial and continued focus on drug repurposing to treat rare diseases, Recursion Pharmaceuticals has broadened its platform to probe rich data from high-throughput automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. Recursion Pharmaceuticals is aggressively leveraging technology to build a robust and reliable map of human cellular biology, which will enable a radical shift in the pace and scale at which new treatments will benefit patients. It is a biotechnology company based in Salt Lake City and was founded in 2013.

Invests into

Technology: NeuroTech
Industry: Artificial Intelligence, Bioinformatics, Biotechnology, Pharmaceutical, Wellness
Headquarters: Salt Lake City, Utah, United States
Founded Date: 2013-11-05
Employees Number: 101-250
Funding Status: Late Stage Venture
Acquisitions Number: 1
Investors Number: 28
Total Funding: $465.4M
Estimated Revenue: $10M to $50M
Last Funding Type: Series D

Visit Website
Register and Claim Ownership